Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Combined prednisone and cyclosporine therapy led to excellent hair regrowth and improved well-being.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

A woman with severe angioedema improved significantly after treatment with rituximab.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The patient with lupus and Degos' disease showed significant improvement with treatment.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

A compromised gut may trigger the autoimmune hair loss condition Alopecia Areata.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.